Infusion of HER2 CAR-T cells causes T cell proliferation and IFN- and IL-2 release in an orthotopic murine glioblastoma xenograft model, mediating the regression of HER2-positive glioblastoma [237]. Here, ERBB2 is linked to glioblastoma.